Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The market for stereotactic surgery devices has seen remarkable growth recently, driven by advances in medical technology and increasing demand for precise neurological treatments. This sector is evolving rapidly as healthcare providers seek innovative solutions for minimally invasive brain procedures. Below is a detailed overview of the current market landscape, key growth factors, segmentation, emerging trends, major players, and regional insights.
Stereotactic Surgery Devices Market Size and Growth Outlook
The stereotactic surgery devices market experienced significant expansion over recent years and is projected to continue this upward trajectory. From a market value of $22.44 billion in 2025, it is expected to rise to $23.84 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.2%. Looking ahead, the market is forecasted to reach $30.94 billion by 2030, growing at a CAGR of 6.7%. This expansion is primarily due to the growing prevalence of neurological disorders, increased establishment of neurosurgical centers, widespread use of gamma knife technology, adoption of minimally invasive brain surgeries, and ongoing improvements in medical imaging systems.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10495&type=smp
Factors Encouraging Market Expansion in the Coming Years
The surge in demand for precision neurosurgery is a major factor driving the stereotactic surgery devices market forward. More healthcare providers are investing in cutting-edge radiosurgery platforms that enable highly accurate, targeted treatments. Additionally, the incorporation of artificial intelligence (AI) in surgical planning is revolutionizing the field by offering enhanced capabilities and greater customization. Alongside these technological advancements, there is a rising preference for non-invasive treatment methods, which reduce patient risk and recovery time.
Key Trends Shaping the Future of the Stereotactic Surgery Devices Market
The market is witnessing an increasing adoption of image-guided stereotactic systems, which allow surgeons to navigate complex brain structures with improved precision. Another notable trend is the growing use of robotic-assisted platforms that facilitate minimally invasive procedures. High-precision navigation technologies are becoming more integrated into surgical workflows, contributing to better treatment outcomes. Furthermore, the expansion of non-invasive radiosurgery solutions underscores the industry’s focus on patient safety and treatment accuracy.
Access The Complete Stereotactic Surgery Devices Market Report:
https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report
How Rising Neurological Disorders Influence Market Demand
The increasing incidence of Parkinson’s disease and epilepsy is significantly contributing to market growth. Parkinson’s disease, characterized by symptoms such as tremors, slow movement, and muscle rigidity, alongside epilepsy, which leads to recurrent seizures, represent major neurological challenges worldwide. Stereotactic surgical devices play a vital role in managing these conditions by offering targeted therapies. For example, a report from the British Psychological Society in November 2024 highlights that in Wales alone, around 100,000 people live with long-term neurological diseases, including over 41,000 individuals affected by conditions like Parkinson’s, epilepsy, multiple sclerosis, and others. With approximately 2,500 new cases diagnosed annually, these trends are accelerating demand for stereotactic surgery solutions.
The Impact of Aging Populations on Market Growth
An expanding elderly population is further propelling the need for stereotactic surgery devices. Defined as individuals aged 65 and above, this demographic often requires specialized, minimally invasive treatments to address age-associated neurological disorders. According to the World Health Organization (WHO) in October 2025, by 2030, one out of every six people globally will be aged 60 or older. The number of elderly individuals is projected to double by 2050, reaching 2.1 billion. This demographic shift underscores the growing necessity for advanced stereotactic surgical interventions tailored to geriatric health needs.
Market Segmentation Overview for Stereotactic Surgery Devices
This market is categorized based on product type, application, and end user. The product segment includes Gamma Knife systems, Linear Accelerator (LINAC) machines, and CyberKnife platforms. From an application standpoint, treatments cover brain tumors, arteriovenous malformations, Parkinson’s disease, epilepsy, and other neurological conditions. End users comprise hospitals, specialized neurosurgical centers, cancer treatment facilities, and academic and research medical institutions. Further subcategories break down product lines, such as Leksell Gamma Knife Perfexion and Icon models, conventional and IGRT LINAC systems, and CyberKnife M6 and VSI systems.
Innovations and Technological Advances Shaping Market Dynamics
Leading companies in the stereotactic surgery devices field are focusing on enhancing tracking and positioning technologies to boost procedural precision and improve patient safety. These innovations enable real-time monitoring and more efficient workflows during stereotactic interventions like radiosurgery and radiation therapy. For example, in May 2023, Brainlab launched the ExacTrac Dynamic Surface system, which combines high-speed thermal surface tracking with improved X-ray monitoring. This technology uses structured blue light patterns and thermal imaging to enable highly accurate patient alignment, especially for cranial and spine treatments, thereby elevating the reliability and control of stereotactic procedures.
Key Players Dominating the Stereotactic Surgery Devices Market
Prominent organizations leading this market include Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, Ion Beam Applications S.A., ZAP Surgical Systems Inc., Brainlab AG, Monteris Medical Holding AG, Renishaw plc, Medtronic plc, Nexstim Plc, FHC Inc., Alpha Omega Engineering Inc., Mitsubishi Heavy Industries Ltd., Inomed Medizintechnik GmbH, MRI Interventions Inc., Modus Medical Devices Inc., Scopis GmbH, Neuropace Inc., Adeor Medical AG, and Huiheng Group Co Ltd.
Regional Market Leadership and Outlook
In 2025, North America was the dominant region in the stereotactic surgery devices market. The comprehensive market report also covers other critical regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a global perspective on evolving market trends and growth potential.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
